RCE recce pharmaceuticals ltd

News: RCE Recce Pharmaceuticals Announces Positive & Concentration-Dependent Efficacy Of Recce®...

  1. 193,698 Posts.
    lightbulb Created with Sketch. 2825

    Sept 10 (Reuters) - Recce Pharmaceuticals Ltd (RCE) :

    • RECCE PHARMACEUTICALS ANNOUNCES POSITIVE & CONCENTRATION-DEPENDENT EFFICACY OF RECCE® COMPOUNDS AGAINST COVID-19 IN INTERNATIONAL STUDY
    • RECCE PHARMACEUTICALS - R327, R529 COMPOUNDS SHOW CONCENTRATION-DEPENDENT FALL IN COVID-19 IN-VITRO STUDY USING ORGANOIDS MADE FROM HUMAN AIRWAY EPITHELIAL CELLS
    • RECCE PHARMACEUTICALS - CONCENTRATIONS OF R327, R529 TESTED, FURTHER INDICATED EXCELLENT TOXICITY PROFILE ON VERO CELLS, IN SEPARATE BUT RELATED STUDY
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
42.0¢
Change
0.005(1.20%)
Mkt cap ! $120.0M
Open High Low Value Volume
42.0¢ 42.0¢ 42.0¢ $1.26K 3K

Buyers (Bids)

No. Vol. Price($)
4 139680 40.0¢
 

Sellers (Offers)

Price($) Vol. No.
42.0¢ 58604 2
View Market Depth
Last trade - 09.59am 13/08/2025 (20 minute delay) ?
RCE (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.